Verastem
Price & Volume
Stats
See more52W Range | $2.54-$11.25 |
Market Cap | $565.6M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $2.1M |
Revenue Growth (YoY) | -78.6% |
Gross Profit (12 Mos) | $1.8M |
Diluted EPS | -$3.50 |
News
See moreYahoo Finance • 2 months ago
Earnings call transcript: Verastem Q2 2025 sees revenue growth and FDA approval
Yahoo Finance • 2 months ago
Verastem stock rises after LGSOC treatment data published in medical journal
Yahoo Finance • 2 months ago
Verastem's cancer drug shows 31% response rate in ovarian cancer trial
Yahoo Finance • 3 months ago
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
About
CEO | Mr. Daniel W. Paterson |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |
